These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Guidelines for the treatment of vitiligo. Antoniou C; Katsambas A Drugs; 1992 Apr; 43(4):490-8. PubMed ID: 1377115 [TBL] [Abstract][Full Text] [Related]
4. Treatment of vitiligo: current methods and new approaches. Kostović K; Nola I; Bucan Z; Situm M Acta Dermatovenerol Croat; 2003; 11(3):163-70. PubMed ID: 12967509 [TBL] [Abstract][Full Text] [Related]
5. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study. Saraceno R; Nisticò SP; Capriotti E; Chimenti S Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584 [TBL] [Abstract][Full Text] [Related]
6. Autologous epidermal grafting with PUVA-irradiated donor skin for the treatment of vitiligo. Lee AY; Jang JH Int J Dermatol; 1998 Jul; 37(7):551-4. PubMed ID: 9679700 [TBL] [Abstract][Full Text] [Related]
8. Vitiligo. Pathogenesis and treatment. Njoo MD; Westerhof W Am J Clin Dermatol; 2001; 2(3):167-81. PubMed ID: 11705094 [TBL] [Abstract][Full Text] [Related]
9. Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate. Awad SS; Abdel-Raof H; Hosam El-Din W; El-Domyati M J Cosmet Dermatol; 2007 Jun; 6(2):119-24. PubMed ID: 17524129 [TBL] [Abstract][Full Text] [Related]
10. Vitiligo surgical, laser, and alternative therapies: a review and case series. Wassef C; Lombardi A; Khokher S; Rao BK J Drugs Dermatol; 2013 Jun; 12(6):685-91. PubMed ID: 23839187 [TBL] [Abstract][Full Text] [Related]
11. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes. Hossani-Madani A; Halder R G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273 [TBL] [Abstract][Full Text] [Related]
12. Depigmentation therapy with Q-switched ruby laser after tanning in vitiligo universalis. Kim YJ; Chung BS; Choi KC Dermatol Surg; 2001 Nov; 27(11):969-70. PubMed ID: 11737134 [TBL] [Abstract][Full Text] [Related]
13. Repigmentation of vitiligo-associated leukotrichia after autologous, non-cultured melanocyte-keratinocyte transplantation. Al Jasser MI; Ghwish B; Al Issa A; Mulekar SV Int J Dermatol; 2013 Nov; 52(11):1383-6. PubMed ID: 23834588 [TBL] [Abstract][Full Text] [Related]
14. Treatment of vitiligo with a melanocyte-keratinocyte cell suspension versus dermabrasion only: a pilot study with a 12-month follow up. Vázquez-Martínez OT; Martínez-Rodríguez HG; Velásquez-Arenas L; Baños-González D; Ortíz-López R; Padilla-Rivas G; Welsh O; Ocampo-Candiani J J Drugs Dermatol; 2011 Sep; 10(9):1032-6. PubMed ID: 22052273 [TBL] [Abstract][Full Text] [Related]
15. Update on skin repigmentation therapies in vitiligo. Falabella R; Barona MI Pigment Cell Melanoma Res; 2009 Feb; 22(1):42-65. PubMed ID: 19040503 [TBL] [Abstract][Full Text] [Related]
17. A case study to evaluate the treatment of vitiligo with khellin encapsulated in L-phenylalanin stabilized phosphatidylcholine liposomes in combination with ultraviolet light therapy. de Leeuw J; van der Beek N; Maierhofer G; Neugebauer WD Eur J Dermatol; 2003; 13(5):474-7. PubMed ID: 14693493 [TBL] [Abstract][Full Text] [Related]
18. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocyte transplantation. Hong WS; Hu DN; Qian GP; McCormick SA; Xu AE Br J Dermatol; 2011 Sep; 165(3):520-5. PubMed ID: 21564070 [TBL] [Abstract][Full Text] [Related]
19. Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study. Budania A; Parsad D; Kanwar AJ; Dogra S Br J Dermatol; 2012 Dec; 167(6):1295-301. PubMed ID: 22897617 [TBL] [Abstract][Full Text] [Related]